Antitumor effects of antibody-diphtheria toxin conjugates: use of hapten-coated tumor cells as an antigenic target.
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001666:Binding Sites, Antibody; D002460:Cell Line; D006224:Cricetinae; D004140:Dinitrophenols / Q000008:administration & dosage; D004167:Diphtheria Toxin / Q000008:administration & dosage; D005260:Female; D005354:Fibrosarcoma; D006241:Haptens; D007279:Injections, Subcutaneous; D009368:Neoplasm Transplantation; D011817:Rabbits / Q000276:immunology; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013539:Simian virus 40; D014184:Transplantation, Homologous
D000906:Antibodies; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D004140:Dinitrophenols; D004167:Diphtheria Toxin; D006241:Haptens